Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Practices and Outcomes during a Watch and Wait Approach for Follicular Lymphoma: A Study from the Australasian Lymphoma Alliance

Luani Barge, Joshua W.D. Tobin, Niamh Waters, Ross Salvaris, Sam Lai, Tessa Potezny, Helen Cashman, Caitlyn Nguyen-Ngo, Denise Lee, Costas K. Yannakou, Nada Hamad, Constantine S. Tam, Abir Bhattacharyya, Chan Y. Cheah, Kirk Morris, Eliza A. Hawkes, Greg Hapgood

Blood (2024) 144 (Supplement 1): 4416.

https://doi.org/10.1182/blood-2024-203146

Published: 2024

Journal Articles

The Nature of High-Risk Defining Events in Follicular Lymphoma Determines Overall Survival

Blood (2023) 142 (Supplement 1): 1671.

https://doi.org/10.1182/blood-2023-185879

Published: 2023

Journal Articles

A Window Study of Acalabrutinib & Rituximab, Followed By Chemotherapy & Autograft (ASCT) in Fit Patients with Treatment Naïve Mantle Cell Lymphoma (MCL): First Report of the Investigator-Initiated Australasian Leukaemia & Lymphoma Group NHL33 ‘Wamm’ Trial

Blood (2023) 142 (Supplement 1): 735.

https://doi.org/10.1182/blood-2023-178403

Published: 2023

Journal Articles

Age, Albumin, and LDH Predict Outcome of Patients with Limited Stage Peripheral T Cell Lymphoma: A Prognostic Model Developed on 244 Cases Enrolled in the T Cell Project 1 By the International T Cell Project Network

Blood (2022) 140 (Supplement 1): 1476–1478.

https://doi.org/10.1182/blood-2022-158883

Published: 2022

Journal Articles

The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Blood (2021) 138 (Supplement 2): LBA-1.

https://doi.org/10.1182/blood-2021-154729

Published: 2021

Journal Articles

High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients

Katharine Louise Lewis, Lasse H. Jakobsen, Diego Villa, Sabela Bobillo, Karin Ekstroem Smedby, Kerry J. Savage, Toby A. Eyre, Kate Cwynarski, Paris L Caporn, Joan Van Zyl, Magdalena Klanova, Marek Trněný, Robert Puckrin, Douglas A. Stewart, Mark J Bishton, Christopher P. Fox, Aung M Tun, Gita Thanarajasingam, Faouzi Djebbari, Erel Joffe, Sandra Eloranta, Sara Harrysson, Laurie H. Sehn, Seth M Maliske, Kittika Poonsombudlert, Xiao Guo, Greg Hapgood, Kate Manos, Eliza Hawkes, Jahanzaib Khwaja, Adrian Minson, Michael Dickinson, Andreas Kiesbye Øvlisen, Gareth P Gregory, Michael Gilbertson, Isaac T Streit, Hamish W Scott, Matthew Ku, Sanjay de Mel, Kar Ying Yong, Liu Xin, Mridula Mokoonlall, Dipti Talaulikar, Nicholas L McVilly, Anna Johnston, Matthew J Brunner, Priyanka A Pophali, Matthew J. Maurer, Tarec Christoffer El-Galaly, Chan Yoon Cheah

Blood (2021) 138 (Supplement 1): 181.

https://doi.org/10.1182/blood-2021-146737

Published: 2021

Journal Articles

A Window Study of Acalabrutinib Plus Rituximab Followed By R-Dhaox (rituximab, dexamethasone, cytarabine, oxaliplatin) and Autologous Stem Cell Transplant (ASCT) in Fit Mantle Cell Lymphoma (MCL): The Australasian Leukaemia & Lymphoma Group (ALLG) NHL33 Wamm Trial

Eliza Hawkes, Shivam Agrawal, Sze-Ting Lee, Joel Wight, Greg Hapgood, Tasman Armytage, Nicole Wong Doo, Tara Cochrane, Chan-Yoon Cheah, Ian Bilmon, Matthew Ku, Stephen Opat, Bianca Devitt, Chun Yew Fong, Tineke Fancourt, Mannu Walia, Gloria Nkhoma, Allison Barraclough

Blood (2021) 138 (Supplement 1): 4516.

https://doi.org/10.1182/blood-2021-149308

Published: 2021

Journal Articles

Cardiac Morbidity in Adolescents and Young Adult Survivors of Hodgkin Lymphoma

Kristin C. Marr, MD, Jonathan Simkin, MPH, Andrea C. Lo, MD, Joseph M. Connors, MD, Alina S. Gerrie, MD MPH, Diego Villa, MDMPH, Ciara L. Freeman, MSc, MBBChir, David W. Scott, MBChB, PhD, Greg Hapgood, BMBS, FRACP, FRCPA, Laurie H. Sehn, MDMPH, Ryan Woods, MSc PhD, Kerry J. Savage, MDMSc

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-136454

Published: 2020

Journal Articles

A Cost-Effectiveness Analysis of Front-Line Treatment Strategies in Early Stage Follicular Lymphoma

Joshua W.D. Tobin, MD, Greg Hapgood, BMBS, FRACP, FRCPA, Maher K. Gandhi, PhDFRACP,FRCPath, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Ti Ma, BSci, Anna Crothers, Paul Scuffham

Blood (2020) 136 (Supplement 1): 54–55.

https://doi.org/10.1182/blood-2020-138590

Published: 2020

Journal Articles

Management and Outcomes of Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in the PET/CT Era: A Multicentre Study from the Australasian Lymphoma Alliance

Blood (2020) 136 (Supplement 1): 36–38.

https://doi.org/10.1182/blood-2020-140665

Published: 2020

Journal Articles

Management and Outcomes of Testicular Lymphoma in the Rituximab Era at an Australian Tertiary Centre

Aarya Murali, MBBS (Hons), Stephen Boyle, MBChB, BSc(Hons), MRCP(UK), Peter Mollee, FRACP,MBBS,MSc,FRCPA, Greg Hapgood, BMBS, FRACP, FRCPA

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-138440

Published: 2020

Journal Articles

Outcomes of Stage I and II Follicular Lymphoma in the Era of 18F-FDG PET-CT Staging: An International Collaborative Study from the Australian Lymphoma Alliance

Blood (2018) 132 (Supplement 1): 4148.

https://doi.org/10.1182/blood-2018-99-114097

Published: 2018

Journal Articles

An International Multicenter Retrospective Comparison of Induction Chemoimmunotherapy Regimens on Outcomes in Patients with Transplant-Eligible Mantle Cell Lymphoma

Blood (2017) 130 (Supplement 1): 4052.

https://doi.org/10.1182/blood.V130.Suppl_1.4052.4052

Published: 2017

Journal Articles

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

Kerry J. Savage, MDMSc, Joseph M. Connors, MD, Diego R Villa, MDMPH, Greg Hapgood, MD, Alina S Gerrie, MD, Tamara N Shenkier, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne, Francois Benard, MD, James Morris, MD, Tom Pickles, MD, Christina Parsons, MD, Don Wilson, MD, Laurie H. Sehn

Blood (2015) 126 (23): 579.

https://doi.org/10.1182/blood.V126.23.579.579

Published: 2015

Journal Articles

Flow Cytometric Characterization of 129 Cases of Peripheral T Cell Lymphoma Not Otherwise Specified (PTCL NOS) and Angioimmunoblastic T Cell Lymphoma (AITL)

Greg Hapgood, MD, Anja Mottok, MD, Graham W Slack, MD, Randy D. Gascoyne, Christian Steidl, MD, Kerry J. Savage, MDMSc, Andrew P. Weng, MD PhD

Blood (2015) 126 (23): 2667.

https://doi.org/10.1182/blood.V126.23.2667.2667

Published: 2015

Journal Articles

The biology and management of systemic anaplastic large cell lymphoma

Greg Hapgood, Kerry J. Savage

Blood (2015) 126 (1): 17–25.

https://doi.org/10.1182/blood-2014-10-567461

Published: 2015

Journal Articles

An Assessment of the Differences in Erythropoiesis Between Transfused Males and Females with β Thalassaemia Major

Greg Hapgood, BMBS, Timothy Walsh, MBBS, Ronit Cukierman, MBBS, Eldho Paul, MPH, Ken Cheng, MBBS, Donald K Bowden, MBBS

Blood (2014) 124 (21): 4045.

https://doi.org/10.1182/blood.V124.21.4045.4045

Published: 2014

Journal Articles

Primary Cutaneous Anaplastic Large Cell Lymphoma: The British Columbia Cancer Agency Experience

Greg Hapgood, BMBS, Laurie H. Sehn, MDMPH, Diego Villa, MDMPH, Richard Klasa, MD, Alina S. Gerrie, MD MPH, Randy D. Gascoyne, MD, Christina Parsons, MD, James Morris, MD, Tom Pickles, MD, Joseph M. Connors, MD, Kerry J. Savage, MDMSc

Blood (2014) 124 (21): 3076.

https://doi.org/10.1182/blood.V124.21.3076.3076

Published: 2014

NARROW

Practices and Outcomes during a Watch and Wait Approach for Follicular Lymphoma: A Study from the Australasian Lymphoma Alliance

The Nature of High-Risk Defining Events in Follicular Lymphoma Determines Overall Survival

A Window Study of Acalabrutinib & Rituximab, Followed By Chemotherapy & Autograft (ASCT) in Fit Patients with Treatment Naïve Mantle Cell Lymphoma (MCL): First Report of the Investigator-Initiated Australasian Leukaemia & Lymphoma Group NHL33 ‘Wamm’ Trial

Age, Albumin, and LDH Predict Outcome of Patients with Limited Stage Peripheral T Cell Lymphoma: A Prognostic Model Developed on 244 Cases Enrolled in the T Cell Project 1 By the International T Cell Project Network

The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients

A Window Study of Acalabrutinib Plus Rituximab Followed By R-Dhaox (rituximab, dexamethasone, cytarabine, oxaliplatin) and Autologous Stem Cell Transplant (ASCT) in Fit Mantle Cell Lymphoma (MCL): The Australasian Leukaemia & Lymphoma Group (ALLG) NHL33 Wamm Trial

Cardiac Morbidity in Adolescents and Young Adult Survivors of Hodgkin Lymphoma

A Cost-Effectiveness Analysis of Front-Line Treatment Strategies in Early Stage Follicular Lymphoma

Management and Outcomes of Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in the PET/CT Era: A Multicentre Study from the Australasian Lymphoma Alliance

Management and Outcomes of Testicular Lymphoma in the Rituximab Era at an Australian Tertiary Centre

Outcomes of Stage I and II Follicular Lymphoma in the Era of 18F-FDG PET-CT Staging: An International Collaborative Study from the Australian Lymphoma Alliance

An International Multicenter Retrospective Comparison of Induction Chemoimmunotherapy Regimens on Outcomes in Patients with Transplant-Eligible Mantle Cell Lymphoma

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

Flow Cytometric Characterization of 129 Cases of Peripheral T Cell Lymphoma Not Otherwise Specified (PTCL NOS) and Angioimmunoblastic T Cell Lymphoma (AITL)

The biology and management of systemic anaplastic large cell lymphoma

An Assessment of the Differences in Erythropoiesis Between Transfused Males and Females with β Thalassaemia Major

Primary Cutaneous Anaplastic Large Cell Lymphoma: The British Columbia Cancer Agency Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only